Literature DB >> 22446413

Characterization of the uterine leiomyoma microRNAome by deep sequencing.

Boryana Georgieva1, Ivan Milev, Ivan Minkov, Irina Dimitrova, Andrew P Bradford, Vesselin Baev.   

Abstract

MicroRNAs (miRNAs) are a class of small non-coding RNAs, which are negative regulators of gene expression. Many genes in human uterine leiomyoma (ULM) are aberrantly expressed and in some cases this can be due to dysregulation of miRNAs. Here we present the first study to determine genome-wide miRNA expression patterns in uterine leiomyoma and myometrium using Solexa high-throughput sequencing. We found more than 50 miRNAs, which were differentially expressed, and furthermore we extend the list of putative new miRNA genes. The top five significantly de-regulated miRNAs in ULMs that we found in our libraries were miR-363, miR-490, miR-137, miR-217 and miR-4792. We also observed "isomiRs" with higher copy number than referenced mature miRNA specific for the leiomyoma libraries, which have a potential role in tumorigenesis. The microRNA transcriptomes obtained in this study deliver insights and further expand our understanding the role of small RNAs in uterine leiomyoma development.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22446413     DOI: 10.1016/j.ygeno.2012.03.003

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  30 in total

1.  miR-363 induces transdifferentiation of human kidney tubular cells to mesenchymal phenotype.

Authors:  Ryuji Morizane; Shizuka Fujii; Toshiaki Monkawa; Ken Hiratsuka; Shintaro Yamaguchi; Koichiro Homma; Hiroshi Itoh
Journal:  Clin Exp Nephrol       Date:  2015-09-15       Impact factor: 2.801

2.  Identification and functional analysis of microRNA in myometrium tissue from spontaneous preterm labor.

Authors:  Yao Tang; Hongjing Ji; Haiyan Liu; Weirong Gu; Xiaotian Li; Ting Peng
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  microRNA-363 plays a tumor suppressive role in osteosarcoma by directly targeting MAP2K4.

Authors:  Xueqin Li; Xinsheng Liu; Jun Fang; Huazhuang Li; Jingchun Chen
Journal:  Int J Clin Exp Med       Date:  2015-11-15

4.  Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.

Authors:  Zhaofeng Chen; Xiaoguang Liu; Zenan Hu; Yuping Wang; Min Liu; Xiaojun Liu; Hailong Li; Rui Ji; Qinhong Guo; Yongning Zhou
Journal:  Oncol Lett       Date:  2015-05-06       Impact factor: 2.967

Review 5.  The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.

Authors:  Qiwei Yang; Aymara Mas; Michael P Diamond; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2015-04-28       Impact factor: 3.060

6.  Decreased expression of microRNA-29 family in leiomyoma contributes to increased major fibrillar collagen production.

Authors:  Erica E Marsh; Marissa L Steinberg; J Brandon Parker; Ju Wu; Debabrata Chakravarti; Serdar E Bulun
Journal:  Fertil Steril       Date:  2016-05-24       Impact factor: 7.329

Review 7.  Tissue-specific stem cells in the myometrium and tumor-initiating cells in leiomyoma.

Authors:  Masanori Ono; Serdar E Bulun; Tetsuo Maruyama
Journal:  Biol Reprod       Date:  2014-11-05       Impact factor: 4.285

8.  Next-generation sequencing reveals differentially expressed small noncoding RNAs in uterine leiomyoma.

Authors:  Tsai-Der Chuang; Yeming Xie; Wei Yan; Omid Khorram
Journal:  Fertil Steril       Date:  2018-05       Impact factor: 7.329

9.  MicroRNA-363-3p Inhibits the Expression of Renal Fibrosis Markers in TGF-β1-Treated HK-2 Cells by Targeting TGF-β2.

Authors:  Xiangnan Dong; Yang Li; Rui Cao; Honglan Xu
Journal:  Biochem Genet       Date:  2021-02-25       Impact factor: 1.890

Review 10.  Macrophages and Immune Responses in Uterine Fibroids.

Authors:  Alessandro Zannotti; Stefania Greco; Pamela Pellegrino; Federica Giantomassi; Giovanni Delli Carpini; Gaia Goteri; Andrea Ciavattini; Pasquapina Ciarmela
Journal:  Cells       Date:  2021-04-22       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.